MUNDIPHARMA ESTABLISHES AN OPHTHALMOLOGY BUSINESS BY ACQUIRING MSD’S PORTFOLIO OF GLAUCOMA PRODUCTS

Published on - December 3, 2015

The portfolio consists of COSOPT®, COSOPT® Preservative-Free, SAFLUTAN®, TIMOPTIC®, TIMOPTIC XE®, TIMOPTIC® Preservative-Free, TRUSOPT® and…

Read More >

MUNDIPHARMA EXPANDS SPECIALISED CANCER TREATMENT PORTFOLIO WITH THE ACQUISITION OF SPECTRUM’S JAPAN AFFILIATE AND MULTI-MARKET ZEVALIN® ACQUISITION

Published on - November 18, 2015

Acquisition from Spectrum Pharmaceuticals leverages upon Mundipharma’s existing regulatory and marketing investments. Under the License…

Read More >

MUNDIPHARMA DEMONSTRATES EFFICACY OF BETADINE® FORMULATIONS AGAINST EBOLA VIRUS

Published on - January 26, 2015

SINGAPORE, 26 January 2015 – Mundipharma today announces successful results from the testing of BETADINE®…

Read More >

MUNDIPHARMA DONATES BETADINE® ANTI-VIRAL SUPPLIES TO DIRECT RELIEF TO SUPPORT THE FIGHT AGAINST EBOLA IN WEST AFRICA

Published on - October 24, 2014

Mundipharma to provide supplies for at least two million hand washes in Ebola treatment centres…

Read More >

NEW, CONVENIENT OPTION AIMS TO IMPROVE ASTHMA MANAGEMENT FOR SUFFERERS IN SINGAPORE

Published on - October 24, 2014

Mundipharma to provide supplies for at least two million hand washes in Ebola treatment centres…

Read More >

MUNDIPHARMA ANNOUNCES PLANS TO DISTRIBUTE MEDIFOAM® IN CHINA

Published on - January 14, 2014

Mundipharma will distribute Medifoam®, an innovative moist wound dressing, in China in early 2015 This…

Read More >
↓